Cargando…

Mizoribine: A New Approach in the Treatment of Renal Disease

Mizoribine (MZB) is an imidazole nucleoside and an immunosuppressive agent. The immunosuppressive effect of MZB has been reported to be due to the inhibition of DNA synthesis in the S phase of the cell cycle. Because of its relative lack of toxicity, during the past decade MZB has been frequently us...

Descripción completa

Detalles Bibliográficos
Autor principal: Kawasaki, Yukihiko
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801010/
https://www.ncbi.nlm.nih.gov/pubmed/20052390
http://dx.doi.org/10.1155/2009/681482
_version_ 1782175891012452352
author Kawasaki, Yukihiko
author_facet Kawasaki, Yukihiko
author_sort Kawasaki, Yukihiko
collection PubMed
description Mizoribine (MZB) is an imidazole nucleoside and an immunosuppressive agent. The immunosuppressive effect of MZB has been reported to be due to the inhibition of DNA synthesis in the S phase of the cell cycle. Because of its relative lack of toxicity, during the past decade MZB has been frequently used instead of azathioprine as a component of immunosuppressive drug regimens. MZB is being used to treat renal transplantation patients, IgA nephropathy, lupus erythematosus, and childhood nephrotic syndrome (NS), and some recent studies have assessed the efficacy of oral MZB pulse therapy for severe lupus nephritis, steroid-resistant NS, and frequently relapsing-steroid-dependent NS. This review summarizes the published findings on the efficacy of MZB for renal disease including IgA nephropathy, lupus nephritis, and NS, as well as of oral MZB pulse therapy for severe lupus nephritis and NS, and also the mechanism of the effect of oral MZB pulse therapy on the lymphocyte cell cycle.
format Text
id pubmed-2801010
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-28010102010-01-05 Mizoribine: A New Approach in the Treatment of Renal Disease Kawasaki, Yukihiko Clin Dev Immunol Review Article Mizoribine (MZB) is an imidazole nucleoside and an immunosuppressive agent. The immunosuppressive effect of MZB has been reported to be due to the inhibition of DNA synthesis in the S phase of the cell cycle. Because of its relative lack of toxicity, during the past decade MZB has been frequently used instead of azathioprine as a component of immunosuppressive drug regimens. MZB is being used to treat renal transplantation patients, IgA nephropathy, lupus erythematosus, and childhood nephrotic syndrome (NS), and some recent studies have assessed the efficacy of oral MZB pulse therapy for severe lupus nephritis, steroid-resistant NS, and frequently relapsing-steroid-dependent NS. This review summarizes the published findings on the efficacy of MZB for renal disease including IgA nephropathy, lupus nephritis, and NS, as well as of oral MZB pulse therapy for severe lupus nephritis and NS, and also the mechanism of the effect of oral MZB pulse therapy on the lymphocyte cell cycle. Hindawi Publishing Corporation 2009 2009-12-13 /pmc/articles/PMC2801010/ /pubmed/20052390 http://dx.doi.org/10.1155/2009/681482 Text en Copyright © 2009 Yukihiko Kawasaki. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Kawasaki, Yukihiko
Mizoribine: A New Approach in the Treatment of Renal Disease
title Mizoribine: A New Approach in the Treatment of Renal Disease
title_full Mizoribine: A New Approach in the Treatment of Renal Disease
title_fullStr Mizoribine: A New Approach in the Treatment of Renal Disease
title_full_unstemmed Mizoribine: A New Approach in the Treatment of Renal Disease
title_short Mizoribine: A New Approach in the Treatment of Renal Disease
title_sort mizoribine: a new approach in the treatment of renal disease
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801010/
https://www.ncbi.nlm.nih.gov/pubmed/20052390
http://dx.doi.org/10.1155/2009/681482
work_keys_str_mv AT kawasakiyukihiko mizoribineanewapproachinthetreatmentofrenaldisease